-
Characteristics of Patients With Bullous Pemphigoid in the US Medicare Population
Mar 10, 2025, 14:00 PM -
Healthcare Resource U tilization and Healthcare Costs After Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The ENDURE Study
Mar 10, 2025, 14:00 PM -
Comparison of an Innovative Static Model With Dynamic Adjustment With a Dynamic Model To Assess the Public Health Impact of TAK-003 Vaccination: Case Studies in Thailand and Brazil
Mar 10, 2025, 14:00 PM -
Conceptual Framework for a De Novo Cost-effectiveness Model in Glycogen Storage Disease Type Ia (GSDIa)
Mar 10, 2025, 14:00 PM -
Cost Comparison of Osimertinib Plus Chemotherapy Versus Amivantamab Plus Lazertinib for the First-Line Treatment of Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated With First-Line Platinum-Based Chemotherapy (PBC) and =2 Subsequent Lines of Therapy in the United States
Mar 10, 2025, 14:00 PM -
Disparities in Breast Cancer Screening Rates are Compounded by Type of Insurance Coverage and Social Drivers of Health
Mar 10, 2025, 14:00 PM -
Indirect Costs Associated With Neovascular Age-Related Macular Degeneration (nAMD) in Colombia
Mar 10, 2025, 14:00 PM -
Comparison of Rare Disease Patient and Caregiver Perceptions Regarding Access to Disease Information and Interactions with their Healthcare Providers: Results from an International Survey
Mar 10, 2025, 14:00 PM -
Assessing VYVGART Social Media Data in Generalized Myasthenia Gravis To Understand Patient, Caregiver, and HCP Sentiment
Mar 10, 2025, 14:00 PM -
A Real-World Retrospective Cohort Study Characterizing Patients with MMN in the United States
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Adults 60 Years of Age and Older in Japan
Mar 10, 2025, 14:00 PM -
Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in the Front-Line Maintenance Setting for Advanced Ovarian Cancer (OC): A Trial-Level Meta-Analysis
Mar 10, 2025, 14:00 PM -
Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population
Mar 10, 2025, 14:00 PM -
The Global Economic Burden of Type 1 Diabetes: Current Estimates and Projections to 2040
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization in the Management of Patients with Relapse/Refractory Mantle Cell Lymphoma in Canada
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization of Tafamidis Patients in the United States
Mar 10, 2025, 14:00 PM -
Economic Impact of Trastuzumab and Its Biosimilars for the Treatment of HER2-Positive Breast Cancer Patients: A Real-World Study in the US
Mar 10, 2025, 14:00 PM -
Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Measuring Patient- and Carer-Reported Outcomes Following Genome Sequencing for Rare Disease Diagnosis: A Psychometric Assessment of Outcome Measurement Instruments
Mar 10, 2025, 14:00 PM